Akshatha Shetty
Psychiatry · Naperville, ILNPI 1932289329
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 32.2% of the total.
Across 133 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$907
- Takeda Pharmaceuticals U.S.A., Inc.$293
- Sunovion Pharmaceuticals Inc.$196
- Lundbeck LLC$150
- Johnson & Johnson$129
- Alkermes, Inc.$128
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $907 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $293 |
| Sunovion Pharmaceuticals Inc. | 10 | $196 |
| Lundbeck LLC | 9 | $150 |
| Johnson & Johnson | 5 | $129 |
| Alkermes, Inc. | 7 | $128 |
| Vanda Pharmaceuticals Inc. | 6 | $122 |
| Corium, LLC | 5 | $112 |
| Neuronetics, Inc. | 3 | $110 |
| Neurocrine Biosciences, Inc. | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Harmony Biosciences LLC | 2 | $71 |
| Tris Pharma Inc | 3 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 2 | $45 |
| Shire North American Group Inc | 2 | $36 |
| Indivior Inc. | 2 | $35 |
| Neos Therapeutics, LP | 2 | $29 |
| USWM, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Pear Therapeutics (US), Inc. | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$2,815 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 18 | $193 |
| Clonazepam | 30 | $106 |
| Escitalopram Oxalate | 16 | $103 |
| Lamotrigine | 19 | $98 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Naperville
- Caroline MorrisonNaperville$44K
- Sandeep GaonkarNaperville$31K
- Philip JanicakNaperville$17K
- Petrit NdrioNaperville$16K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.